High-Dose chemo tested for rare, aggressive bone cancer in kids and adults

NCT ID NCT03011528

Summary

This study tested an intensive chemotherapy treatment for Ewing sarcoma, a rare bone cancer, in patients aged 2 to 50 whose cancer had already spread to bones or bone marrow at diagnosis. The goal was to see if a strong initial chemotherapy regimen could help more patients become eligible for a final, high-dose chemotherapy treatment with stem cell support. The trial enrolled 45 participants to measure survival rates and how well the cancer responded to this aggressive approach.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EWING SARCOMA FAMILY OF TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Bordeaux Chu

    Bordeaux, 33076, France

  • CHRU Montpellier - Hôpital A. de Villeneuve

    Montpellier, 34295, France

  • CHU Grenoble Alpes

    Grenoble, 38043, France

  • CHU Hôpital Sud

    Rennes, 35056, France

  • Chr Felix Guyon

    La Réunion, Saint Denis, 97400, France

  • LILLE Centre Oscar Lambret

    Lille, 59000, France

  • LYON Centre Léon Bérard

    Lyon, 69000, France

  • Marseille Chu

    Marseille, 13000, France

  • NANCY Institut de Cancérologie de Lorraine

    Vandœuvre-lès-Nancy, 54519, France

  • Nancy Chu

    Vandœuvre-lès-Nancy, 54511, France

  • Nantes Chu

    Nantes, 44000, France

  • PARIS Institut Curie

    Paris, 75005, France

  • PARIS Trousseau

    Paris, 75012, France

  • Strasbourg Chu

    Strasbourg, 67098, France

  • TOULOUSE Institut Claudius Regaud

    Toulouse, 31059, France

  • Toulouse Chu

    Toulouse, 31059, France

  • VILLEJUIF Institut Gustave Roussy

    Villejuif, 94805, France

Conditions

Explore the condition pages connected to this study.